Skip to search formSkip to main contentSkip to account menu

Savaysa

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

edoxabanedoxaban tosylate
edoxaban 60 MG Oral Tablet [Savaysa]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Edoxaban (Savaysa) for the Prevention of Thromboembolic Events.
Edoxaban is an alternative to warfarin and other oral anticoagulants for the prevention of stroke in patients with nonvalvular… 
2016
2016
Daiichi Sankyo to Present Findings From New Subgroup Analyses of Once-Daily SAVAYSA ® (edoxaban) in NVAF and VTE at ACC's 65th Annual Scientific Session
2015
2015
Edoxaban approved for embolism prevention.
FDA and Daiichi Sankyo on January 8 announced the approval of edoxaban, an oral factor Xa inhibitor, to reduce the risk of stroke… 
2015
2015
Daiichi Sankyo, Inc. Announces New Subgroup Analyses of Once-Daily SAVAYSA ® in Patients with Non-Valvular Atrial Fibrillation Will Be Presented at AHA Scientific Sessions 2015
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)